Barnett v. Surefire Med., Inc.
Opinion
PHILIP A. BRIMMER, United States District Judge
This matter comes before the Court on Defendants' Motion to Dismiss Plaintiff's Seventh Claim for Unjust Enrichment and Memorandum of Points and Authorities in Support Thereof [Docket No. 18]. The Court has jurisdiction pursuant to
I. BACKGROUND1
This case involves a patented design for an anti-reflux catheter. See Docket No. 1 at 1. Plaintiff alleges that he developed the design in 2007 while working at Johns Hopkins Medical Institution ("JHMI") under the supervision of defendant Aravind Arepally.
As an inventor at JHMI, plaintiff claims he was "contractually entitled to compensation for commercialization of any patent that issued based on his invention pursuant to [Johns Hopkins University's] Intellectual Property Policy." Docket No. 1 at 8, 12-13, ¶¶ 20, 32. He further states that "there is a definitive reputational advantage [in academia] to being named an inventor on patents that result in medical products as well as receiving research grants utilizing said technology."
Plaintiff filed this lawsuit on October 16, 2017 asserting six claims for correction of inventorship and damages in relation to various patents issued to Surefire, and one claim for unjust enrichment against Dr. Arepally. See
II. LEGAL STANDARD
Free access — add to your briefcase to read the full text and ask questions with AI
PHILIP A. BRIMMER, United States District Judge
This matter comes before the Court on Defendants' Motion to Dismiss Plaintiff's Seventh Claim for Unjust Enrichment and Memorandum of Points and Authorities in Support Thereof [Docket No. 18]. The Court has jurisdiction pursuant to
I. BACKGROUND1
This case involves a patented design for an anti-reflux catheter. See Docket No. 1 at 1. Plaintiff alleges that he developed the design in 2007 while working at Johns Hopkins Medical Institution ("JHMI") under the supervision of defendant Aravind Arepally.
As an inventor at JHMI, plaintiff claims he was "contractually entitled to compensation for commercialization of any patent that issued based on his invention pursuant to [Johns Hopkins University's] Intellectual Property Policy." Docket No. 1 at 8, 12-13, ¶¶ 20, 32. He further states that "there is a definitive reputational advantage [in academia] to being named an inventor on patents that result in medical products as well as receiving research grants utilizing said technology."
Plaintiff filed this lawsuit on October 16, 2017 asserting six claims for correction of inventorship and damages in relation to various patents issued to Surefire, and one claim for unjust enrichment against Dr. Arepally. See
II. LEGAL STANDARD
To survive a motion to dismiss under Rule 12(b)(6) of the Federal Rules of Civil Procedure, a complaint must allege enough factual matter that, taken as true, makes the plaintiff's "claim to relief...plausible on its face." Khalik v. United Air Lines ,
"Although a statute of limitations bar is an affirmative defense, it may be resolved on a Rule 12(b)(6) motion to dismiss 'when the dates given in the complaint make clear that the right sued upon has been extinguished.' " Torrez v. Eley ,
III. ANALYSIS
Defendants argue that plaintiff's unjust enrichment claim accrued no later than August 6, 2013, the date on which the '755 Patent was issued, and is therefore barred by the three-year statute of limitations in
A. Whether a Six-Year Limitations Period Applies
Although the parties' briefs discuss the choice of law issue first, the Court will begin by addressing whether the six-year limitations period under
Under Colorado law, "[e]quitable claims...are technically subject to an equitable laches rather than a legal statute of limitations analysis." Sterenbuch v. Goss ,
Colorado courts have typically assessed unjust enrichment claims, which are brought in quasi-contract or contract implied in law, "under the three-year statute of limitations for contract actions."
Section 13-80-103.5(1)(a) provides, in relevant part, that a six-year limitations period applies to "[a]ll actions to recover a liquidated debt or an unliquidated, determinable amount of money due to the person bringing the action." Defendants argue that plaintiff's complaint "does not allege either a liquidated debt or a 'determinable amount' allegedly misappropriated by Arepally," and thus the three-year limitations *1172period under
In Portercare Adventist Health System v. Lego ,
Plaintiff argues that his unjust enrichment claim also seeks recovery of a readily ascertainable sum because plaintiff seeks a percentage of the $135,000 Arepally has received in connection with the "commercialization of the patented inventions." Docket No. 19 at 11. The Court disagrees. While courts have applied the six-year statute of limitations in § 13-80-103.5(1)(a) to breach of contract and unjust enrichment claims, they have done so only when the parties' agreement or other extrinsic evidence in existence at the time of the loss provided a clear method for calculating the amount owed. See, e.g. , Torres-Vallejo v. Creativexteriors, Inc. ,
B. Choice of Law
Defendant contends that plaintiff's unjust enrichment claim is governed by either Colorado law or Maryland law and is time-barred by the three-year statute of limitations applicable under each. See Docket No. 18 at 4 & n.2 (stating that an "in depth" conflict of laws analysis is unnecessary because "the relevant law of Maryland, the only other jurisdiction with significant contacts with the occurrence and the parties, does not differ from the law of Colorado"). Plaintiff counters that "it is far from clear" that Colorado law governs plaintiff's claims. Docket No. 19 at 5. He further suggests that the law of Georgia, which imposes a four-year statute of limitations on unjust enrichment claims, may apply. See Docket No. 19 at 5-6.6 Plaintiff states that, "[a]t a minimum," he should be allowed discovery on the facts pertinent to the choice of law issue presented in this case. Id. at 6.
Because the Court is exercising supplemental jurisdiction over plaintiff's unjust enrichment claim, the Court applies the substantive law of Colorado, the forum state, including its choice of law rules. See BancOklahoma Mortg. Corp. v. Capital Title Co., Inc. ,
*1174Wood Bros. Homes, Inc. v. Walker Adjustment Bureau ,
(a) the place where a relationship between the parties was centered, provided that the receipt of enrichment was substantially related to the relationship, (b) the place where the benefit or enrichment was received, (c) the place where the act conferring the benefit or enrichment was done, (d) the domicil, residence, nationality, place of incorporation and place of business of the parties, and (e) the place where a physical thing, such as land or chattel, which was substantially related to the enrichment, was situated at the time of the enrichment.
Because a three-year limitations period applies to plaintiff's claim under both Colorado and Maryland law, see Jason v. Nat'l Loan Recoveries, LLC ,
Applying the factors listed above, the Court agrees with defendant that either Colorado or Maryland has the "most significant relationship" to plaintiff's claim. The parties' relationship was centered in Maryland, where plaintiff alleges that he and defendant Arepally worked together at JHMI and were subject to Johns Hopkins' Intellectual Property Policy, under which students, faculty, and employees are entitled to compensation for inventions developed at the university. See Docket No. 1 at 4, 8, 12, ¶¶ 7, 20, 32. The act conferring the benefit, plaintiff's sharing of information related to the anti-reflux catheter design, also occurred in Maryland while plaintiff was under defendant Arepally's supervision. See id. at 4, ¶¶ 9-10. As for the domicile, residency, and place of business of the parties, this factor weighs in favor of Colorado. Although the parties are domiciled in Maryland (plaintiff), Colorado (Surefire), and Georgia (Arepally), Colorado is both Surefire's place of domicile as well as the state in which Arepally regularly conducts business relevant to the claims asserted in the complaint. See id. at 2-3, ¶ 2.
Plaintiff argues that "it is not clear from what location [Arepally] performed the services [for which he received compensation] or if the benefits were conferred to him in Georgia." Docket No. 19 at 5. However, plaintiff alleges that Arepally conducted in Colorado "those activities that form the basis for [the] complaint." Docket No. 1 at 2-3, ¶ 2. While it is not clear whether Arepally received compensation for his consulting services in Colorado or Georgia, his place of residence, the Court finds this factor insufficient to establish *1175Georgia as the state with the most significant relationship to plaintiff's claim given that both the parties' relationship and the act conferring the benefit occurred in Maryland. See Restatement (Second) § 221, Comment on Subsection (2) ("The place where a relationship between the parties was centered, provided that [the] relationship was substantially related to the receipt of enrichment, is the contract that, as to most issues, is given the greatest weight in determining the state of the applicable law."); see also id. ("Particular weight ... will be given to the state where the act conferring the benefit or enrichment was done in situations where the place where the benefit or enrichment was received cannot be identified or where this place differs from that where the act conferring the benefit was done and bears little relation to the occurrence and the parties.").8
In summary, the allegations establish that the law of either Maryland or Colorado governs the statute of limitations applicable to plaintiff's unjust enrichment claim.
C. Date of Claim Accrual
The Court next addresses when plaintiff's unjust enrichment claim accrued. Defendants argue that the claim accrued on August 6, 2013, the date the '775 Patent issued, because that is the date on which plaintiff knew or should have known that he was not named as an inventor. See Docket No. 18 at 6. Plaintiff responds that his claim did not accrue until 2015 when defendant Arepally began receiving compensation for consulting services provided in relation to the '775 patent. Docket No. 19 at 11-12; see also Docket No. 1 at 28, ¶ 102.
An unjust enrichment claims accrues "when a person discovers, or through the exercise of reasonable diligence should discover, that all elements of the claim are present." Hannon Law Firm, LLC v. Melat, Pressman & Higbie, LLP ,
The parties' disagreement over the date on which plaintiff's unjust enrichment claim accrued turns on the meaning of "benefit." Plaintiff contends that Arepally did not receive any benefit from the issuance of the '775 Patent in 2013 because all right, title, and interest to the patent had been assigned to Surefire. Docket No. 19 at 11. However, plaintiff's argument that the claim did not accrue until Arepally received payment for the consulting services he provided in connection with the catheter design conflates Arepally's improperly retained "benefit" with the profits *1176he received as a result of that benefit. The Tenth Circuit's decision in Grynberg v. Total S.A. ,
Similar to Grynberg , plaintiff's unjust enrichment claim in this case is based on defendant Arepally's intentional "misappropriation and use of [plaintiff's design]" for which plaintiff was entitled to compensation. See Docket No. 1 at 28-29, ¶¶ 103-106. Thus, under Grynberg , plaintiff's claim accrued when he knew or should have known that Arepally had misappropriated and used plaintiff's design without providing compensation, not when plaintiff learned that Arepally had obtained profits from the misappropriation. In arguing that Arepally did not receive any benefit until 2015, plaintiff construes the concept of "benefit" too narrowly, Dudding ,
*1177The Court finds the allegations in the complaint sufficient to establish that plaintiff knew or should have known of the facts underlying his unjust enrichment claim at the time the '775 Patent was issued on August 6, 2013. Plaintiff alleges that, "[i]n August 2012, while Surefire's first patent application was still pending, [Johns Hopkins University] brought Barnett's contribution" to the catheter design "to Surefire's attention"; however, "Surefire refused to acknowledge Barnett's rights or to discuss his positions directly with him." Docket No. 1 at 17, ¶ 46. The '775 Patent issued on August 6, 2013. See Docket No. 1-3 at 2. The patent lists Arepally and three other individuals as the inventors of the patented design, and Surefire as the "assignee." Docket No. 1-3 at 2. Based on these facts, plaintiff "knew or should have known that he was not named as an inventor" on the '775 Patent more than three years before he filed his complaint. Docket No. 18 at 6; see also Gen. Elec. Co. v. Galbiati , No. 13-cv-02053-RPM,
D. Equitable Issues
In addition to his legal arguments regarding the applicable limitations period, plaintiff makes four equitable arguments for allowing his claim to proceed.13
Plaintiff first contends that, because six years is the limitations period applicable under both federal patent law and Colorado law for claims in which the damages sought are easily ascertainable, a six-year limitations period should apply here. See Docket No. 19 at 14. Plaintiff's argument is merely a reiteration of arguments already addressed by this Court and will be rejected for the same reasons stated above.
Second, plaintiff asserts that Surefire and Arepally have "known since 2012 that Barnett has been trying to resolve the issues that are the subject of his Complaint," yet they failed to disclose that Arepally "is personally liable for Surefire's actions related to the patented inventions" and have "actively sought to avoid engaging in meaningful discussions to resolve the matter." Docket No. 19 at 14. Plaintiff cites no authority indicating that defendants were obligated to either disclose Arepally's alleged personal liability or engage in discussions to resolve the parties' dispute. Rather than support the equitable tolling of the limitations period, plaintiff's assertions confirm the Court's conclusion that plaintiff knew or should have known of his cause of action long before he filed his complaint.
*1178Plaintiff's third argument is that "it would be entirely inequitable to allow Arepally to avoid his personal obligations to [plaintiff]" because "Arepally has been involved every step of the way in the events that give rise to [plaintiff's] Complaint." Id. at 14. While this argument may support a finding of liability on the part of Arepally, it does not provide a basis for equitable tolling.
Finally, plaintiff contends that he "has been stymied at every turn by Defendants, including Arepally, in trying to address the inventorship issues," and that defendants have "actively sought to prevent [plaintiff] from learning the truth." Id. at 14-15. To the extent that these allegations are distinct from plaintiff's second argument, they are too vague to warrant equitable tolling.
IV. CONCLUSION
For the foregoing reasons, it is
ORDERED that Defendants' Motion to Dismiss Plaintiff's Seventh Claim for Unjust Enrichment and Memorandum of Points and Authorities in Support Thereof [Docket No. 18] is GRANTED in part and DENIED in part as stated in this order. It is further
ORDERED that plaintiff's seventh claim for relief is hereby dismissed.
Footnotes
342 F. Supp. 3d 1167 (Barnett v. Surefire Med., Inc.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.